Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-18

FDA Approved: CYANOCOBALAMIN — Original Application (Vitruvias Therapeutics)

View source ↗

Summary

FDA approved the original application for cyanocobalamin from Vitruvias Therapeutics, enabling a generic cyanocobalamin product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYANOCOBALAMIN (cyanocobalamin)

Snippet

ORIG AP for CYANOCOBALAMIN (CYANOCOBALAMIN)